MELATONIN: Overview, Uses, Side Effects, Precautions, Interactions ...
The Hepatitis A Outbreak Linked To Various Brands Of Frozen Organic Strawberries Has Gotten Worse
Although it may be tempting to pick up some frozen strawberries during your next grocery run, the Food and Drug Administration advises against doing so.
Turns out, frozen berries are linked to an ongoing Hepatitis A outbreak, which began around Nov. 24, 2022. On April 12, 2023, the Centers for Disease Control and Prevention announced that the patient count in the outbreak increased to a total of eight outbreak-associated cases reported from California and Washington.
As of April 21, 2023, the patient count remains the same. Two out of the eight individuals have been hospitalized. No deaths have been reported.
"Epidemiologic and traceback evidence indicate that frozen organic strawberries, imported fresh from certain farms located in Baja California, Mexico in 2022, are the likely source of this outbreak," the CDC wrote. "The hepatitis A virus strain causing illnesses in this outbreak is genetically identical to the strain that caused a foodborne hepatitis A outbreak in 2022, which was linked to fresh organic strawberries imported from Baja California, Mexico, and sold at various retailers."
The affected brands include Simply Nature (distributed in Arizona, Arkansas, California, Illinois, Iowa, Michigan, Minnesota, Missouri, North Dakota, Ohio, South Dakota, Wisconsin), Vital Choice (distributed in Washington), Kirkland Signature (distributed in Alaska, Idaho, Montana, Oregon, Utah, Washington), Made With (distributed in Illinois and Maryland), PCC Community Markets (distributed in Washington) and Trader Joe's (distributed nationwide).
Amid an investigation led by the CDC, state public health and regulatory officials and the FDA, California Splendor, Inc. Of San Diego, California voluntarily recalled certain lots of 4-lb. Bags of Kirkland Signature Frozen Organic Whole Strawberries that were sold at Costco stores in Los Angeles; Hawaii; and two San Diego business centers. Similarly, Scenic Fruit Company of Gresham, Oregon, voluntarily recalled frozen organic strawberries, sold to Costco, Trader Joe's, Aldi, KeHE, Vital Choice Seafood and PCC Community Markets in certain states. On March 17, 2023, Meijer also voluntarily recalled Made-With brand frozen organic strawberries from certain market store locations.
Want more great food writing and recipes? Subscribe to Salon Food's newsletter, The Bite.
Hepatitis A is a highly contagious liver infection caused by the hepatitis A virus. The virus itself is commonly found in the stool and blood of those who are infected. It is spread from close, personal contact with an infected person or via ingestion, usually from eating contaminated food or drink. Hepatitis A can be prevented with a vaccine, which is recommended for all children at age one and at-risk adults, per the CDC.
At this time, the CDC "recommends that people who purchased recalled frozen organic strawberries should not eat, serve, or sell these recalled frozen organic strawberries." If you have eaten any of the recalled frozen organic strawberries and are not vaccinated against Hepatitis A, contact your local health department or health care provider immediately.
The FDA's investigation into the outbreak is ongoing. More products may be added to the recall list soon.
Read more
about the FDA and CDC:
Hepatitis B Vaccine Market 2023 Size Is Anticipated To Reach USD 10.62 Billion By 2029-CAGR 4.5%
The MarketWatch News Department was not involved in the creation of this content.
Apr 27, 2023 (The Expresswire) -- The global "hepatitis b vaccine market 2023" was estimated at USD 7.53 Billion in 2021. Fortune Business Insights predicts the market to reach USD 10.62 Billion by 2029, with a CAGR of 4.5% during the forecast period (2022-2029). The report covers global industry size, the latest trends, regional share, demand, recent developments and business opportunities. The report is titled, "Hepatitis B Vaccine Market Analysis and Forecast, 2023- 2029"
Request Free Sample PDF:https://www.Fortunebusinessinsights.Com/enquiry/request-sample-pdf/107098
In-depth analysis with a focus on the worldwide market trend, the hepatitis b vaccine market is examined until the year 2029. The report's primary goal is to give readers a comprehensive picture of the global market, including a breakdown of the industry by product/application and geography. During the projected time, there will be a significant increase in worldwide demand. In addition to offering important trends and opportunities in the market, the research report delivers critical statistics on the competitive landscape for hepatitis b vaccine market.
Key Topics Covered in the Hepatitis B Vaccine Market Report:
Factors affecting the global hepatitis b vaccine market:
The most recent report by Fortune Business Insights identifies key opportunities for market expansion over the forecast period. This report plots market opportunities using a detailed study of the current hepatitis b vaccine market scenario, mergers and acquisitions, investments in research and development, technological developments, novel marketing strategies, and buyers' behaviour. The critical opportunities covered in the report will provide a better understanding of the global hepatitis b vaccine market and its future growth.
Speak to Analyst for Queries:https://www.Fortunebusinessinsights.Com/enquiry/speak-to-analyst/107098
List of Key Players Covered in the Report:
The use of the hepatitis b vaccine market report can help investors to make more informed decisions, access a wider range of investment options, and achieve their financial goals more effectively. Additionally, the market for hepatitis b vaccine market is growing rapidly, driven by factors covered in the report. As a result, the market is expected to continue to grow in the forecasted years.
Major Points in TOC:
TOC Continued……………
Quick Buy - Hepatitis B Vaccine Market Report:https://www.Fortunebusinessinsights.Com/checkout-page/107098
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights, we aim to highlight the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact:
Email:sales@fortunebusinessinsights.Com
Phone: US +1 424 253 0390 / UK +44 2071 939123 / APAC: +91 744 740 1245
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Hepatitis B Vaccine Market 2023 Size is Anticipated To Reach USD 10.62 Billion by 2029-CAGR 4.5%
COMTEX_430345058/2598/2023-04-27T04:35:18
Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.Com. You can also contact MarketWatch Customer Service via our Customer Center.
The MarketWatch News Department was not involved in the creation of this content.
You Can Access Hepatitis B Vaccine From Public Health Facilities
HEALTH ;;HEPATITIS B ;;VACCINATION
Starting April 24 to April 30 is the annual commemoration of the African Week of Vaccination. ; ;
In honour of the week's activities, ensure to get vaccinated against Hepatitis B. ;
Data indicates that Hepatitis B has continued to be one of the main health challenges in the country. The national prevalence of Hepatitis B is unacceptably high at 4.3% among the adult population aged between 15 to 64 in Uganda, according to a UPHIA survey conducted in 2016. ;
The same survey indicates that the prevalence of Hepatitis B in children is lower at 0.6%.
The distribution of the virus varies from area to area, with the highest figures being recorded in the districts of the northern region of Uganda at 4.6%. ;
This is followed by North East at 4.4% and 3.8% in West Nile. The prevalence rate in East–Central stands at 2.7%, in Mid-East it stands at 2.1%, for Kampala, it stands at 1.9%, for Mid-West, it is at 1.8% and in Central 1, the prevalence stands at 1.6 and it is lowest in South West at 0.8%.
Understanding Hepatitis B
Hepatitis B is a viral infection that attacks the liver and causes both acute and chronic diseases such as scarring of the liver, liver cancer and chronic liver failure, if not treated early, according to Dr. Ponsiano Ocama, a liver specialist.
The virus is commonly transmitted from the mother to the child during birth and delivery, as well as through contact with blood or other body fluids.
In the acute phase, the infected person presents symptoms such as fever, yellowing of the eyes, headache, body pain, nausea, abdominal pain and vomiting after about 20 years from the time of exposure, Dr Ocama says. ;
Who is at risk?
Dr. Micheal Baganize, who is the manager UNEPI at the health ministry says people living in areas with a high prevalence of Hepatitis B virus such as districts in the northern region are most at risk. ;
Dr. Baganize says the best way of avoiding contracting the disease is through vaccination. Hepatitis B vaccines are available in public health facilities at a free cost. ;
You will be screened first for Hepatitis B and if found negative, you will be given your first dose of the vaccine. A month later, you will receive your second dose and then receive your third dose six months from the time you received the second dose.
Newborns too protected
In October 2022, the Government introduced Hepatitis B vaccination birth dose in the routine immunization as an intervention to reduce the risk of mother-to-child transmission. ;
"We want to have a population that is fully vaccinated right from birth," Dr Baganize says. ;
Some studies have shown that earlier introduction of the Hepatitis B vaccine will result in further improvement in terms of prevention.
Dr. Carol Achola working at Uganda National Health Laboratory Services says new mothers should ensure their newborn babies receive the Hepatitis B vaccine for full protection.
"For all infections acquired in the first year of life, about 80 - 90 % go on to develop into a chronic disease," Dr. Achola says.
Provided by SyndiGate Media Inc. (Syndigate.Info).
Comments
Post a Comment